BT Wealth Management LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 80 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
BT Wealth Management LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$118,000
-27.6%
60,000
+5.2%
0.07%
-18.1%
Q4 2019$163,000
-22.0%
57,0090.0%0.08%
-29.1%
Q3 2019$209,000
+10.6%
57,0090.0%0.12%
+7.3%
Q2 2019$189,000
-26.2%
57,009
+14.0%
0.11%
-27.8%
Q1 2019$256,000
+2.8%
50,0000.0%0.15%
+41.1%
Q4 2018$249,00050,0000.11%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders